Abstract Even with new drugs available, how best to treat unfit adults with acute myeloid leukemia (AML) remains uncertain. In a previous trial in such patients, we found high-dose cytarabine-based therapy with CLAG-M yielded higher response rates but no more toxicity than lower-intensity therapy with dose-attenuated CLAG-M.
Ryan D. Cassaday
Seattle
Husband of Dr. Emily Stevens MD PhD. ALL Doctor. Product of 2 UW's. Tweets are mine and do not constitute medical advice.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ryan D.
Contact Ryan D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack